During the past decade, Retina Consultants of Hawaii conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 14 clinical trials were completed, i.e. on average, 60.9% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 9 clinical trials were completed. i.e. 90% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Retina Consultants of Hawaii" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Retina Institute of Hawaii" with 7 trials sponsored, "Jaeb Center for Health Research" with 3 trials sponsored, "Clearside Biomedical, Inc." with 2 trials sponsored and "Hawaii Pacific Health" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retina Consultants of Hawaii" #1 collaborator was "Genentech, Inc." with 6 trials as a collaborator, "National Eye Institute (NEI)" with 3 trials as a collaborator, "Regeneron Pharmaceuticals" with 3 trials as a collaborator, "Chugai Pharmaceutical" with 2 trials as a collaborator and "Allergan" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Retina Consultants of Hawaii" are "Diabetic Macular Edema" (9 trials), "Macular Edema" (5 trials), "Geographic Atrophy" (4 trials), "Macular Degeneration" (4 trials) and "Polypoidal Choroidal Vasculopathy" (4 trials). Many other conditions were trialed in "Retina Consultants of Hawaii" in a lesser frequency.

Most popular intervention types in "Retina Consultants of Hawaii" are "Drug" (33 trials), "Other" (6 trials), "Procedure" (5 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (8 trials), "Aflibercept" (6 trials), "Faricimab" (6 trials), "Ranibizumab" (3 trials) and "Sham" (3 trials). Other intervention names were less common.

The vast majority of trials in "Retina Consultants of Hawaii" are 41 trials for "All" genders.

Currently, there are NaN active trials in "Retina Consultants of Hawaii". undefined are not yet recruiting, 1 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Retina Consultants of Hawaii, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Retina Consultants of Hawaii, 5 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".